# Postoperative Anti-infective Strategy Following Pancreaticoduodenectomy in Patients With Preoperative Biliary Stent

> **NCT06123169** · PHASE3 · NOT_YET_RECRUITING · sponsor: **University Hospital, Rouen** · enrollment: 326 (estimated)

## Conditions studied

- Pancreaticoduodenectomy
- Antibiotherapy

## Interventions

- **DRUG:** Antibioprophylaxis (Piperacillin-tazobactam)
- **DRUG:** 5 days Antibiotherapy (Piperacillin-tazobactam)

## Key facts

- **NCT ID:** NCT06123169
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2028-07
- **Final completion:** 2028-07
- **Target enrollment:** 326 (ESTIMATED)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06123169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06123169, "Postoperative Anti-infective Strategy Following Pancreaticoduodenectomy in Patients With Preoperative Biliary Stent". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT06123169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*